Chris Rozell

Chris Rozell leads the Structured Information for Precision Neuroengineering Lab at Georgia Tech and is the inaugural director of the Institute for Neuroscience, Neurotechnology, and Society. He discusses groundbreaking methods using deep brain stimulation and AI to treat treatment-resistant depression. Chris highlights how neural signals can predict treatment effectiveness and the importance of personalized care in mental health. Their conversation delves into the evolving techniques in neuromodulation and the necessity of interdisciplinary research to enhance future therapies.